Dietary reversal of experimental hypercholesterolemia improves endothelial dysfunction of epicardial arteries but not of small coronary vessels in pigs

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 301-308

  Sattler, Katherine J E ^a   Galili, Offer ^a   Rodriguez Porcel, Martin ^a   Krier, James D ^b   Lerman, Lilach O ^a,b   Lerman, Amir ^a  

^a Mayo Clinic College of Medicine   (United States)

^b Division of Nephrology and Hypertension   (United States)

Author keywords

Cholesterol; Nuclear factor B; Small vessels; Vasorelaxation

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC GMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; HEART MUSCLE; HYPERCHOLESTEROLEMIA; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZATION; SWINE; TISSUE DISTRIBUTION; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; CYCLIC GMP; DIET, ATHEROGENIC; ENDOTHELIUM, VASCULAR; FEMALE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; NADPH OXIDASE; NF-KAPPA B; SUPEROXIDE DISMUTASE; SUS SCROFA;

EID: 33748066636     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.009     Document Type: Article

References (30)

1. Gonzalez M.A., and Selwyn A.P. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 115 Suppl 8A (2003) 99S-106S
2. Schaechinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
3. Chan S.Y., Mancini G.B.J., Kuramoto L., Schulzer M., Frohlich J., and Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 42 (2000) 1037-1043
4. Rodriguez-Porcel M., Lerman L.O., Holmes Jr. D.R., Richardson D., Napoli C., and Lerman A. Chronic antioxidant supplementation attenuates nuclear factor-κB activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 53 (2002) 1010-1018
5. Wilson S.H., Caplice N.M., Simari R.D., Holmes Jr. D.R., Carlson P.J., and Lerman A. Activated nuclear factor-kappa B is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 148 (2000) 23-30
6. Herrmann J., Gulati R., Napoli C., et al. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J 17 (2003) 1730-1732
7. Herrmann J., Ciechanover A., Lerman L.O., and Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res 61 (2004) 11-21
8. Zhu X.Y., Rodriguez-Porcel M., Bentley M.D., et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109 (2004) 2109-2115
9. Mantha S.V., Prasad M., Kalra J., and Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of Vitamin E in rabbits. Atherosclerosis 101 (1993) 135-144
10. Boeger R.H., Bode-Boeger S.M., Muegge A., et al. Supplementation of hypercholesterolaemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117 (1995) 273-284
11. Rodriguez-Porcel M., Lerman L.O., Herrmann J., Sawamura T., Napoli C., and Lerman A. Hypercholesterolemia and hypertension have synergistic deletrious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol 23 (2003) 885-891
12. Wilson S.H., Chade A.R., Feldstein A., et al. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transplant 18 (2003) 703-709
13. Wilson S.H., Simari R.D., Best P.J.M., et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol 21 (2001) 122-128
14. Stulak J.M., Lerman A., Caccitolo J.A., et al. Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia. Atherosclerosis 154 (2001) 195-201
15. Hasdai D., Sangiorgi G., Spagnoli L.G., et al. Coronary artery apoptosis in experimental hypercholesterolemia. Atherosclerosis 142 (1999) 317-325
16. Mingnone C., Gupte S.A., Iesaki T., and Wolin M.S. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries. Am J Physiol 285 (2003) L296-L304
17. Lerman A., Webster M.W., Chesebro J.H., et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 88 (1993) 2923-2928
18. Verhamme P., Quarck R., Hao H., et al. Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res 56 (2002) 135-144
19. Chilian W.M., Eastham C.L., and Marcus M.L. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 251 (1986) H779-H788
20. Prasad A., Higano S.T., Al Suwaidi J., et al. Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction. Am Heart J 146 (2003) 549-554
21. Hasegawa H., Yamamoto R., Takano H., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. J Mol Cell Cardiol 35 (2003) 953-960
22. Node K., Fujita M., Kitakaze M., Hori M., and Liao J.K. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108 (2003) 839-843
23. Bonetti P.O., Wilson S.H., Rodriguez-Porcel M., Holmes Jr. D.R., Lerman L.O., and Lerman A. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. J Am Coll Cardiol 40 (2002) 546-554
24. Stulak J.M., Lerman A., Rodriguez-Porcel M., et al. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol 12 (2001) 1882-1891
25. Moncada S., Rees D.D., Schulz R., and Palmer R.M.J. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88 (1991) 2166-2170
26. Hsich E., Segal B.H., Pagano P.J., et al. Vascular effects following homozygous disruption of p47phox: an essential component of NADPH oxidase. Circulation 101 (2000) 1234-1236
27. Batenburg W.W., Garrelds I.M., van Kats J.P., Saxena P.R., and Danser A.H. Mediators of bradykinin-induced vasorelaxation in human coronary microarteries. Hypertension 43 (2004) 488-492
28. Kemp B.K., and Cocks T.M. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol 120 (1997) 757-762
29. Bengtsson S.H., Gulluyan L.M., Dusting G.J., and Drummond G.R. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol 30 (2003) 849-854
30. Zelko I.N., Mariani T.J., and Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33 (2002) 337-349